Posted Mar. 25, 2013 at 6:40 a.m.

Premium Lock Analysts see GSK moving to acquire drug partner Theravance

Published: 2013-03-25 06:40:37
Updated: 2013-03-25 06:40:37

Print this blog post
GSK GSK

Theravance's projected U.S. approval for its respiratory drugs is fueling speculation of an almost threefold revenue surge and a takeover bid from partner GlaxoSmithKline....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll